China Healthcare System Guide

China operates one of the world's largest healthcare systems, serving a population of over 1.4 billion people. The system has undergone rapid transformation since the 2009 healthcare reform, achieving near-universal basic insurance coverage of over 95% of the population. China's healthcare expenditure reached approximately 9.3 trillion CNY (about $1.3 trillion) in 2024, representing roughly 7.2% of GDP.

The system is organized in a three-tier structure:

• Primary Care: Community health centers, township health centers, and village clinics providing basic services, preventive care, and referrals.
• Secondary Care: County-level and district hospitals handling common diseases, surgeries, and emergency care.
• Tertiary Care: Provincial and national-level hospitals (Grade A tertiary / Class III) providing specialized treatment, research, and training.

Healthcare Administration

The healthcare system is administered by the National Health Commission (NHC), which oversees public health, medical services, health insurance (co-managed with the National Healthcare Security Administration, NHSA), and disease control. The Chinese Center for Disease Control and Prevention (China CDC) manages infectious disease surveillance and response. Since 2018, the NHSA has managed the consolidation of insurance schemes and drug procurement reforms.

This table shows healthcare infrastructure across all 31 provincial-level divisions, ranked by total number of hospitals. Data reflects 2024 statistics from the National Health Commission.

These hospitals are consistently ranked at the top by the Fudan Hospital Rankings and represent the pinnacle of Chinese medical care. Many specialize in particular fields while maintaining comprehensive services.

China's health insurance system has been consolidated into two main schemes since 2016, providing layered coverage for the entire population.

Insurance Schemes

How Insurance Works in Practice

• Deductible: Patients pay out-of-pocket up to a threshold before insurance kicks in (varies by region and scheme).
• Reimbursement Rates: UEBMI typically reimburses 70-90% of inpatient costs; URRBMI reimburses 50-70%. Outpatient reimbursement is generally lower.
• Ceiling: Annual maximum reimbursement caps exist (typically 300,000-600,000 CNY for basic insurance, supplemented by serious illness insurance).
• Drug List: The National Reimbursement Drug List (NRDL) covers 3,088 drugs as of 2024, including 169 new drugs added through volume-based procurement negotiations.

Volume-Based Procurement (VBP)

Since 2018, China has conducted 9 rounds of centralized drug procurement, covering 374 drugs and reducing average prices by over 50%. This has saved patients an estimated 500 billion CNY cumulatively, making essential medicines significantly more affordable across all provinces.

Traditional Chinese Medicine is integrated into China's modern healthcare system, with dedicated TCM hospitals, departments in general hospitals, and a growing body of scientific research. China has over 5,200 TCM hospitals nationwide and approximately 500,000 licensed TCM practitioners.

TCM Hospitals by Province (Top 15)

TCM Integration

• Hospital Integration: 98.5% of general hospitals have TCM departments.
• COVID-19 Response: TCM was widely used during the pandemic, with a 92% usage rate among confirmed cases in China.
• International Expansion: China has established TCM centers in 196 countries, with WHO inclusion of TCM in the ICD-11 classification system.
• Education: 25 TCM universities produce approximately 100,000 graduates annually.

Major Public Health Achievements

• Infectious Disease Control: China has eliminated polio, neonatal tetanus, and malaria. HIV/AIDS prevalence remains below 0.1%.
• Vaccination: National immunization program covers 15 diseases with over 95% coverage rates.
• Maternal Health: Maternal mortality ratio reduced to 15.1 per 100,000 live births (2024), down from 1,500 in 1949.
• Infant Health: Infant mortality rate reduced to 4.5 per 1,000 live births (2024).
• Non-Communicable Diseases: Major challenge with ~300 million hypertension patients and ~140 million diabetes patients. NCDs account for 88% of all deaths.
• Mental Health: ~173 million people with mental disorders; 2023 Mental Health Law strengthened community-based care.

Disease Surveillance Network

China operates a three-tier disease surveillance system covering 7,500+ sentinel hospitals and 2,000+ CDC facilities. The system monitors over 40 notifiable infectious diseases in real-time. Post-COVID reforms have strengthened early warning capabilities and emergency response mechanisms.

Hierarchical Medical System (2015-present)

The government is promoting a tiered treatment model where patients first visit community health centers for primary care, with referrals to higher-level hospitals only when needed. This aims to reduce overcrowding at major hospitals and improve efficiency. Key measures include differential co-pay rates (lower at primary care) and enhanced primary care capacity.

Centralized Drug Procurement (2018-present)

The VBP program has expanded from 25 drugs in the first round to 374 drugs across 9 rounds, achieving average price reductions of over 50%. The program now covers high-value medical consumables including cardiac stents, artificial joints, and dental implants, with savings exceeding 500 billion CNY.

DRG/DIP Payment Reform (2019-present)

China is transitioning from fee-for-service to Diagnosis-Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment models. By 2024, over 90% of Tier 2+ hospitals have adopted these models, which aim to control costs, improve efficiency, and standardize treatment protocols across hospitals.

Digital Health & Telemedicine

China's National Telemedicine Platform connects over 2,500 hospitals, enabling remote consultations for rural and underserved areas. The Electronic Health Record (EHR) system covers over 85% of the population. AI-assisted diagnosis is being piloted in radiology, pathology, and dermatology across provincial-level hospitals.

Population Aging Challenge

With 297 million people aged 60+ (21.1% of the population) and rapidly aging demographics, China faces increasing healthcare demand. The government has announced plans to expand nursing homes, train geriatric specialists, and increase long-term care insurance coverage. Healthcare spending for the elderly is projected to reach 15% of total health expenditure by 2035.